A new test to find antiviral compounds targeting SARS-CoV-2 RNA
A biophysical assay targeting SARS CoV-2 RNA
This study is looking for new ways to find and target important parts of the SARS-CoV-2 virus's RNA to help create better treatments for COVID-19, which could lead to more effective antiviral medicines for patients.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nubad, LLC NIH-funded |
| Lab location | 1 site (Greer, United States) |
| Project ID | NIH-10653818 on NIH RePORTER |
What this research studies
This research focuses on developing a novel biophysical assay to identify specific RNA structures in the SARS-CoV-2 virus. By using this assay, researchers aim to discover new antiviral compounds that can effectively target these RNA elements, which are crucial for the virus's replication. The approach involves screening for ligands that bind to these RNA structures, potentially leading to the development of new antiviral therapies. Patients may benefit from advancements in treatment options for COVID-19 as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by COVID-19 or those at high risk of severe illness from the virus.
Not a fit: Patients who are not currently affected by COVID-19 or who have already recovered may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral medications specifically targeting SARS-CoV-2, improving treatment options for COVID-19.
How similar studies have performed: Other research has shown promise in targeting viral RNA structures for antiviral drug development, indicating that this approach could be effective.
Where this research is happening
Greer, United States
- Nubad, LLC — Greer, United States (Active)
Researchers
- Principal investigator: Story, Sandra Paige — Nubad, LLC
- Study coordinator: Story, Sandra Paige
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.